Evidence map›Paper›PMID 40463281›Full record

ArticlebioRxiv : the preprint server for biology2025

Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancer.

Sohrab Salehi, Emily E Stroobant, Hannah Lees, Ya-Hui Lin, Shoji Shimada, Miseker Abate, Matthew J Zatzman, Nicholas Ceglia, Samuel S Freeman, Monika Laszkowska and 13 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Sohrab SalehiThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emily E StroobantGastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hannah LeesThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ya-Hui LinHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shoji ShimadaDigestive Disease Center, Showa University, Northern Yokohama Hospital, Yokohama, Japan.
Miseker AbateGastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Matthew J ZatzmanThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-5235-4116
Nicholas CegliaThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9387-103X
Samuel S FreemanThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Monika LaszkowskaGastroenterology, Hepatology, and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Steven MaronGastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew McPhersonThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-5654-5101
Nicole RuskThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eliyahu HavasovThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Harrison DrebinVagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
Ping GuGastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Laura H TangDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yelena Y JanjigianGastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ruslan SoldatovThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ronan ChaligneSingle‑cell Analytics Innovation Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sohrab P ShahThe Halvorsen Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Vivian E StrongGastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Santosha A VardhanaHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-3100-1298

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
A Targeted Approach to the Surveillance of Precursor Lesions for Gastric CancerK08DK125876 · NIDDK · SLOAN-KETTERING INST CAN RESEARCH · PI LASZKOWSKA, MONIKA · 2021 to 2025
$838k
Causal determinants of drug resistance and metastasis in cancer with multimodal single cell dataK99CA277562 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SALEHI, SOHRAB · 2023 to 2024
$232k
NCI NIH HHS K99 CA277562NCI NIH HHS P30 CA008748NIDDK NIH HHS K08 DK125876
6 · The paper itself

Abstract

The gastric mucosa is characterized by continuous innate immune surveillance and inflammatory signaling, yet a high proportion of gastric carcinomas (GCs) are recalcitrant to immune-directed therapies. The mechanisms by which GCs evade adaptive immune surveillance within the highly antigenic microenvironment of the gastric mucosa remains unknown. To address this, we collected patient-matched tumor tissue, distant normal tissue, metastasis, and draining lymph nodes to generate a large-scale single-cell immune profiling dataset from 64 patients (n=179 samples, >150,000 cells). From single cell analysis, we identified two distinct sources of impaired tumor surveillance within tumor draining lymph nodes. First, we observed that a significant fraction of tumor draining lymph nodes had undergone cytokine-driven reprogramming, leading to reduced dendritic cell homing and limited T cell priming. Second, T cells undergoing successful activation exhibited limited expansion and constrained differentiation, marked by expression of the quiescence-associated transcription factor Kruppel-like Factor 2 (

Identifiers

PMID40463281
PMCPMC12132570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.